article thumbnail

GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapy

pharmaphorum

Lab studies have suggested that this type of stimulation can alter immune cells made in the spleen switching them from a pro-inflammation to an anti-inflammation state. Galvani is using its device to stimulate the splenic nerve, which sends signals to the spleen.

article thumbnail

AI drug discovery biotech AbCellera eyes record IPO

pharmaphorum

AbCellera is a specialist in applying artificial intelligence to drug discovery, specifically to sift through immune system data to find antibodies that can be developed as drugs. AbCellera was founded in 2012 and posted $28 million in revenue for the 12 months ending 30 September.

Immunity 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Legislation Would Cut Off Access To The Courts And Immunize FDA Actions From Timely Judicial Review

FDA Law Blog: Biosimilars

Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. 112-144 (2012). Importantly, because FDA has sovereign immunity from damages claims, sponsors trapped in S.

article thumbnail

Transforming oncology with antibody therapeutics

European Pharmaceutical Review

Overall, the mechanisms of action for amivantamab include ligand blocking, receptor degradation, and immune cell-mediated activity. 4 BsMAb amivantamab was designed to enhance adherence of tumour cells to macrophages and natural killer cells, to improve immune-cell mediated killing of cancer cells. 2012; 23(8): 6 – 9.

article thumbnail

IIT Guwahati researchers produce pluripotent stem cells from skin cells

Express Pharma

The most important advantage of iPSCs is their potential to produce patient-specific cells which can be transplanted to the site of injury or the site of tissue degeneration due to various disease conditions, and thereby, eliminate any chance of immune rejection.

article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

This includes treatments, such as immune checkpoint inhibitors , that are extraordinarily effective, but only work for certain patients. The initiative started in 2012, with the aim of gathering 100,000 genetic sequences from participants to then learn more about disease, and disease progression.

article thumbnail

Guest Blog: Climate Change and its Impact on Autoimmune Disease

Putting Patients First Blog

Autoimmune and immune-mediated diseases occur when the body’s immune system works abnormally or attacks itself. Even more concerning, teenagers in the study experienced an almost 300% increase between 1988 and 2012. Chronic exposure to unsafe levels is tied to a 10% increase in developing a variety of immune-mediated diseases.